Global Retirement Partners
FTXH icon

Global Retirement Partners’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Global Retirement Partners’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-350
Closed -$9K – 3045
2022
Q3 		$9K Buy
+350
New +$9.05K ﹤0.01% 1719

Other funds holding FTXH

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Raymond James Financial Services Advisors
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Steward Partners Investment Advisory
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WFA
WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return
Cetera Advisors
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
GSIAS
Garden State Investment Advisory Services Red Bank, New Jersey $553M AUM 31.68% 1-Year Est. Return

Global Retirement Partners's FTXH Position: Q4 2022 in Review

Global Retirement Partners sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q4 2022, closing a stake of 350 shares — an estimated $9K sold.

Global Retirement Partners first reported a position in FTXH in Q3 2022 and held it in 1 quarter. The position peaked at $9K in Q3 2022. 34 funds tracked by Wall St. Rank hold FTXH as of Q4 2022.

  • Global Retirement Partners reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q4 2022 after selling out during the quarter.
  • Global Retirement Partners sold 350 First Trust Nasdaq Pharmaceuticals ETF shares in Q4 2022, an estimated $9K.
  • Global Retirement Partners first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2022 and held it in 1 quarter.
  • Global Retirement Partners's First Trust Nasdaq Pharmaceuticals ETF position peaked at $9K in Q3 2022.
  • 34 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q4 2022.

Based on Global Retirement Partners's 13F filing for Q4 2022, filed 13 Feb 2023.